Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ga-google-analytics domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /opt/bitnami/apache/htdocs/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the twentytwenty domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /opt/bitnami/apache/htdocs/wp-includes/functions.php on line 6121
admin – Covid Guidelines India Skip to the content
Covid Guidelines India Covid Guidelines India
  • Home
  • About us
    • Background & Rationale
    • Project Outline
    • People
      • Core Committee
      • Steering Committee
      • Methodology Committee
      • Evidence Synthesis Team
      • Dissemination Committee
      • External Advisory Panel
      • Antiviral Working Group
      • Anti-inflammatory Working Group
      • Anticoagulation Working Group
      • Antibody Working Group
      • Respiratory Working Group
      • Other Supportive Management Working Group
  • Methods
  • Interventions
    • Antivirals
      • Ivermectin: Updated Recommendation
      • Remdesivir
        • Remdesivir – In patients: Updated Recommendations
        • Remdesivir – Outpatients
      • Favipiravir: Updated Recommendation
      • Molnupiravir: Updated Recommendation
      • Azithromycin
      • Hydroxychloroquine / Chloroquine
      • Interferon
    • Anti-inflammatories
      • Tocilizumab: Updated Recommendation
      • Inhaled Corticosteroids
      • Systemic Corticosteroids
      • Colchicine
      • Baricitinib
      • Itolizumab
      • Sarilumab
    • Anticoagulation
      • Therapeutic dose Vs Nontherapeutic dose of thromboprophylaxis – Updated Recommendation
    • Antibody
      • Casirivimab – Imdevimab
      • Convalescent Plasma
    • Respiratory Therapies
      • NIV vs HFNO
      • Oxygen Saturation Targets
    • Other Supportive Management
      • Prone Positioning
  • Contact us
  • Cite us
  • Home
  • About us
    • Background & Rationale
    • Project Outline
    • People
      • Core Committee
      • Steering Committee
      • Methodology Committee
      • Evidence Synthesis Team
      • Dissemination Committee
      • External Advisory Panel
      • Antiviral Working Group
      • Anti-inflammatory Working Group
      • Anticoagulation Working Group
      • Antibody Working Group
      • Respiratory Working Group
      • Other Supportive Management Working Group
  • Methods
  • Interventions
    • Antivirals
      • Ivermectin: Updated Recommendation
      • Remdesivir
        • Remdesivir – In patients: Updated Recommendations
        • Remdesivir – Outpatients
      • Favipiravir: Updated Recommendation
      • Molnupiravir: Updated Recommendation
      • Azithromycin
      • Hydroxychloroquine / Chloroquine
      • Interferon
    • Anti-inflammatories
      • Tocilizumab: Updated Recommendation
      • Inhaled Corticosteroids
      • Systemic Corticosteroids
      • Colchicine
      • Baricitinib
      • Itolizumab
      • Sarilumab
    • Anticoagulation
      • Therapeutic dose Vs Nontherapeutic dose of thromboprophylaxis – Updated Recommendation
    • Antibody
      • Casirivimab – Imdevimab
      • Convalescent Plasma
    • Respiratory Therapies
      • NIV vs HFNO
      • Oxygen Saturation Targets
    • Other Supportive Management
      • Prone Positioning
  • Contact us
  • Cite us

Nothing Found

CMC Vellore
CIDS (Clinical Infectious Diseases Society)

READ-It
Cochrane Infectious Diseases
Emmanuel Hospital Association

© 2025 Covid Guidelines India

To the top ↑ Up ↑

Please read the following statements and click ‘Agree’ before proceeding:

  • Covid Guidelines India is an evidence-informed living synthesis of evidence and recommendations to support clinical management of COVID-19, developed by a collective of senior clinicians, academics and methodologists at premier medical institutions across India.
  • These guidelines are offered in good faith, to be used at the discretion of the treating clinician and do not reflect the position of the Ministry of Health and Family Welfare or any other section of the Government of India.
  • These guidelines are developed to be contextually relevant to the Indian setting, and for use by hospital-based clinicians managing patients with COVID-19 in India.
  • They are designed to be referred to online, as they will be updated periodically based on updates in the evidence. Use of downloaded or printed versions is not advisable.
  • Using these recommendations will not guarantee successful treatment in every situation. They should not be interpreted as setting a standard of care, or inclusive of all proper methods of care, nor exclusive of other methods of care.
  • Responsibility for the decision to use a treatment or management approach is with the clinician and patient. This should consider the whole situation concerning the patient, including known biological and environmental variability, and feasibility
  • Any of the persons/institutes/organisations involved in creating these recommendations shall not be held liable in case of any direct, indirect, incidental, consequential or any other harm or risk arising out of or in connection with the use of these recommendations.
  • These recommendations may be shared for information dissemination, provided due acknowledgement be given to the Covid Management Guidelines India Group.